| Literature DB >> 28755323 |
Anne Fogli1,2,3,4, Marie-Véronique Demattei5, Laetitia Corset5, Catherine Vaurs-Barrière1,2,3, Emmanuel Chautard6,7, Julian Biau6,7, Jean-Louis Kémény6,8, Catherine Godfraind8,9, Bruno Pereira10, Toufik Khalil11,12, Nathalie Grandin5, Philippe Arnaud1,2,3, Michel Charbonneau13, Pierre Verrelle6,14.
Abstract
Human malignant gliomas exhibit acquisition of either one of two telomere maintenance mechanisms, resulting from either reactivation of telomerase expression or activation of an alternative lengthening of telomeres (ALT) mechanism. In the present study, we analyzed 63 human malignant gliomas for the presence of ALT-specific extrachromosomal circles of telomeric DNA (C-circles) and measured telomerase expression, telomeric DNA content (Telo/Alu method), and telomeric repeat-containing RNAs (TERRA) levels. We also assessed histomolecular markers routinely used in clinical practice. The presence of C-circles significantly correlated with IDH1/2 mutation, MGMT exon 1 methylation, low Ki-67 immunostaining, increased telomeric DNA content, absence of functional ATRX protein and level of HTERT gene expression. In multivariate analysis, we observed a trend to a correlation between elevated TERRA levels and increased survival. Interestingly, the C-circles assay allowed to detect ALT activation in glioblastomas exhibiting wild-type IDH1/2 and ATRX expression. These results suggest that, after the correlations uncovered here have been confirmed on larger numbers of tumors, telomeric markers might be useful in improving diagnosis. They also point out to the utility of using the specific, sensitive and quantitative C-circle and Telo/Alu assays that can work with as few as 30 ng of tumor DNA.Entities:
Keywords: ATRX expression; Alternative lengthening of telomeres; C-circle assay; Gliomas; Telomeric markers
Mesh:
Substances:
Year: 2017 PMID: 28755323 DOI: 10.1007/s11060-017-2585-7
Source DB: PubMed Journal: J Neurooncol ISSN: 0167-594X Impact factor: 4.506